Document Classification

Section Type: RESULTS

Text: However, the salmeterol group had more treatment failures than the triamcinolone group (13/54 [24 %] vs 3/54 [6 %] ; P =. 004), as well as more asthma exacerbations (11/54 [20 %] vs 4/54 [7 %] ; P =. 04), greater increases in median (interquartile range) sputum eosinophils (2. 4 % [0. 0 % to 10. 6 %] vs -0. 1 % [-0. 7 % to 0. 3 %] ; P <. 001), eosinophil cationic protein (71 [-2 to 430] U/L vs -4 [-31 to 56] U/L ; P =. 005), and tryptase (3. 1 [2. 1 to 7. 6] ng/mL vs 0. 0 [0. 0 to 0. 7] ng/mL ; P <. 001).